You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 23, 2025

Patent: 10,023,628


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,023,628
Title:Cell line expressing single chain factor VIII polypeptides and uses thereof
Abstract: The present invention provides cell lines for producing single chain FVIII polypeptides, e.g., chimeric single chain FVIII polypeptides, methods of producing single chain FVIII polypeptides, single chain FVIII polypeptides, and methods of treating Hemophilia A with a single chain Factor VIII polypeptide.
Inventor(s): Low; Susan (Pepperell, MA), Dumont; Jennifer A. (Groton, MA), Bitonti; Alan J. (Acton, MA)
Assignee: Bioverativ Therapeutics Inc. (Waltham, MA)
Application Number:14/412,823
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analyzing the Claims and Patent Landscape of United States Patent 10,023,628

Introduction

When analyzing a patent, particularly one like United States Patent 10,023,628, it is crucial to delve into the claims, the broader patent landscape, and the tools and strategies available for conducting a comprehensive analysis. This article will guide you through the key aspects of patent analysis, using US Patent 10,023,628 as a case study.

Understanding the Patent Claims

Importance of Claims

The claims section of a patent is the most critical part, as it defines the scope of the invention and what is legally protected. For US Patent 10,023,628, the claims must be carefully reviewed to understand the specific technological advancements and the boundaries of the patent protection[2].

Automated Claims Analysis

Given the increasing complexity and number of claims in modern patents, automated tools like the Patent Matrix software can be invaluable. These tools can import, parse, and compress/expanding claims to facilitate a rapid and consistent review, which is essential for keeping pace with the growing volume of patent applications[2].

Conducting a Preliminary Patent Search

Tools and Resources

To analyze the patent landscape around US Patent 10,023,628, one must use various tools and resources provided by the USPTO and other international intellectual property offices.

  • Patent Public Search: This tool offers enhanced access to prior art and is a powerful resource for searching patents and published applications[1].
  • Global Dossier: This service provides access to the file histories of related applications from participating IP offices, helping to identify the patent family and related applications[1].
  • Public Search Facility: Located in Alexandria, VA, this facility offers access to patent and trademark information in various formats, with trained staff available for assistance[1].

International Patent Search

Searching International Databases

To ensure a comprehensive analysis, it is essential to search international patent databases. Resources such as the European Patent Office's esp@cenet, the Japan Patent Office, and the World Intellectual Property Organization's PATENTSCOPE ® Search Service provide access to global patent collections and machine translations for some documents[1].

Advanced Patent Searching Techniques

Utilizing AI and Precision Search Technology

Advanced search platforms and AI algorithms can significantly improve the efficiency of patent searches. For example, AI can help pull in relevant results that might have been missed, and platforms like those offered by CAS can help in understanding the scope and coverage of related patents within a family[4].

Patent Family Searching

Challenges and Solutions

Patent family searching is crucial but can be time-consuming due to complexities such as multi-jurisdiction filing, indexing inconsistencies, language barriers, and claims variations. Tools and services that help in identifying and analyzing the patent family can make informed decisions easier regarding licensing, challenging validity, and resource allocation[4].

Subject Matter Eligibility Analysis

Prong Two of Step 2A

For patents involving AI or other complex technologies, the subject matter eligibility analysis under 35 U.S.C. § 101 is critical. The 2024 Guidance Update emphasizes the importance of Prong Two, which involves demonstrating that the claims are directed to a specific, concrete technological advancement or solution to a technical problem. Crafting strong arguments under Prong Two is essential for overcoming section 101 rejections[3].

Common Citation Document (CCD)

Consolidating Prior Art

The Common Citation Document (CCD) application consolidates prior art cited by all participating offices for the family members of a patent application. This tool helps in visualizing search results from several offices on a single page, facilitating a more integrated and efficient analysis of the patent landscape[1].

Patent Assignment and Examination Data

Tracking Ownership and Examination Status

Tools like the Patent Assignment Search and the Patent Examination Data System (PEDS) allow users to track changes in ownership and examine the status of patent applications. These resources are vital for understanding the current state and potential future developments of a patent[1].

Practical Tips for Patent Analysis

Crafting Effective Arguments

When analyzing and presenting arguments related to a patent, it is important to focus on the practical applicability and technological improvements. Avoid lengthy arguments that might consume the examiner's attention, and instead, emphasize the key elements that demonstrate the patent's value and innovation[3].

Key Takeaways

  • Claims Analysis: The claims section is the heart of a patent, and automated tools can significantly aid in their analysis.
  • Comprehensive Search: Use a combination of USPTO tools, international databases, and advanced search technologies to ensure a thorough search.
  • Subject Matter Eligibility: For AI and complex technologies, focus on Prong Two of Step 2A to demonstrate technological advancements.
  • Patent Family: Analyze the patent family to understand variations in claims and make informed decisions.
  • International Resources: Utilize global databases and machine translations to broaden the search scope.

FAQs

Q: What is the importance of the claims section in a patent?

A: The claims section defines the scope of the invention and what is legally protected, making it the most critical part of a patent.

Q: How can AI tools enhance patent searching?

A: AI tools can improve efficiency by pulling in relevant results that might have been missed and by automating aspects of the search strategy.

Q: What is the Common Citation Document (CCD) and its significance?

A: The CCD consolidates prior art cited by all participating offices for the family members of a patent application, facilitating a more integrated analysis of the patent landscape.

Q: Why is Prong Two of Step 2A important in subject matter eligibility analysis?

A: Prong Two involves demonstrating that the claims are directed to a specific, concrete technological advancement or solution to a technical problem, which is crucial for overcoming section 101 rejections.

Q: Where can I find resources to help with patent searching and analysis?

A: Resources include the USPTO's Patent Public Search, Global Dossier, Public Search Facility, and international databases like those provided by the EPO and WIPO.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. Google Patents - US20110138338A1: https://patents.google.com/patent/US20110138338A1/en
  3. Baker Botts - The Importance of Prong Two of Step 2A for AI Inventions: https://www.bakerbotts.com/thought-leadership/publications/2024/september/the-importance-of-prong-two-of-step-2a-for-ai-inventions
  4. CAS - Advanced patent searching techniques: https://www.cas.org/resources/cas-insights/patent-searching-going-beyond-basics-increase
  5. U.S. Department of Commerce - U.S. Patent and Trademark Office: https://www.commerce.gov/bureaus-and-offices/uspto

More… ↓

⤷  Try for Free

Details for Patent 10,023,628

ApplicantTradenameBiologic IngredientDosage FormBLAApproval DatePatent No.Expiredate
Ferring Pharmaceuticals Inc. NOVAREL chorionic gonadotropin For Injection 017016 January 15, 1974 ⤷  Try for Free 2040-05-01
Ferring Pharmaceuticals Inc. NOVAREL chorionic gonadotropin For Injection 017016 December 27, 1984 ⤷  Try for Free 2040-05-01
Ferring Pharmaceuticals Inc. NOVAREL chorionic gonadotropin For Injection 017016 February 15, 1985 ⤷  Try for Free 2040-05-01
Ferring Pharmaceuticals Inc. NOVAREL chorionic gonadotropin For Injection 017016 February 16, 1990 ⤷  Try for Free 2040-05-01
Bel-mar Laboratories, Inc. CHORIONIC GONADOTROPIN chorionic gonadotropin Injection 017054 March 26, 1974 ⤷  Try for Free 2040-05-01
Fresenius Kabi Usa, Llc CHORIONIC GONADOTROPIN chorionic gonadotropin For Injection 017067 March 05, 1973 ⤷  Try for Free 2040-05-01
>Applicant>Tradename>Biologic Ingredient>Dosage Form>BLA>Approval Date>Patent No.>Expiredate
Showing 1 to 6 of 6 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.